keyboard_arrow_up

Indian In Vitro Diagnostics Market Opportunity Analysis & 2018 Forecasts

The Indian IVD market is valued at more than US$ 500 Million, and is expected to touch the US$ 1 Billion in 2016 growing steady at a CAGR of 19%. This remarkable growth can be attributed to increased healthcare awareness, desire to undergo preventive health checkups, availability of disease specific tests, corporate setups promoting health focus of employees, and drift from manual to semi-automated and automated equipment. Emergence of new concepts like point of care testing, near patient testing, increased automation, hospital laboratory management and customer relationship management have revolutionized this segment and contributed towards providing accurate and precise diagnosis at much faster rates.

Apart from catering to people in the Tier I cities, IVD setups are now eyeing expansion in the Tier II and Tier III cities. This can be attributed to high revenue generating option that lie untapped in these cities clubbed with minimum investment required in order to generate high revenues. These IVD majors tie-up with the existing high reputation laboratory adding value in terms of providing technical help as well as contributing significantly in the advising physicians panel.

Request a sample of this report @ http://bit.ly/1exlQFn.

The Indian IVD market is led majorly by global players in absence of necessary skills, technical knowhow and the infrastructure to bear the high end costs for carrying out research and development of own products possessed by local players. There is massive prevalence of product imported either in finished form or as Original Equipment Manufacturer (OEM) and lesser focus on indigenous research. Market leaders usually offer competitive prices and innovative technologies which have been in use in the developed countries and have been absorbed on a gross scale.

"Indian In Vitro Diagnostics Market Opportunity Analysis 2018" research report is an intriguing text that gives detailed facts and analysis on latest developments in the Indian IVD market landscape. Report discusses various segments of the Indian IVD market and analyzes the factors responsible for the growth and the need to resolve challenges to maintain growth momentum in future.

Purchase a copy of this report @ http://bit.ly/1hKsYyU.

Table of Contents

1. India IVD Market Overview
1.1 Current Market Scenario
1.2 Market Growth Drivers
1.3 Key Challenges to be Resolved

2. IVD Market by Device & Reagents
2.1 Immunochemistry
2.2 Biochemistry.
2.3 Hematology
2.4 Blood Gas & Electrolyte
2.5 Molecular Diagnostics
2.6 Urinalysis
2.7 Coagulation Analysis
2.8 Microbiology

3. Emerging Market Trends
3.1 Rising Lab Automation
3.2 Transition towards preventive health checkups
3.3 Entry of Corporate Chains

4. India IVD Market Future Outlook

5. Regulation & Policy Framework
5.1 Registration of Imported IVD Reagents & Devices
5.2 Registration/ Re-Registration of Notified Medical Devices
5.3 Conducting Clinical Trials of Medical Devices
5.4 Import of Non-Notified Diagnostic Kits
5.5 Import of Notified Diagnostics Kits

6. Competitive Landscape
6.1 Abbott Diagnostic
6.2 Agappe Diagnostics
6.3 Accurex Biomedical
6.4 Transasia Bio-Medicals
6.5 Roche Diagnostics

Complete report available @ http://bit.ly/1m6X8hP

List of Figures

Figure 1-1: In Vitro Diagnostic Market (US$ Million), 2012-2018 
Figure 1-2: In Vitro Diagnostic Market by Reagents & Instruments (US$ Million), 2012-2018
Figure 2-1: Immunochemistry Market (US$ Million), 2012-2018
Figure 2-2: Immunochemistry Market by Reagents & instruments (US$ Million), 2012-2018
Figure 2-3: Immunochemistry Reagents Market by Segment, 2012-2018
Figure 2-4: Biochemistry Market (US$ Million), 2012-2018
Figure 2-5: Biochemistry Market by Reagents & instruments (US$ Million), 2012-2018
Figure 2-6: Biochemistry Instrument Market by Segment, 2012-2018
Figure 2-7: Hematology Market (US$ Million), 2012-2018
Figure 2-8: Hematology Market by Reagents & instruments (US$ Million), 2012-2018
Figure 2-9: Hematology Instrument Market by Segment, 2012-2018
Figure 2-10: Blood Gas & Electrolyte Market (US$ Million), 2012-2018
Figure 2-11: Blood Gas & Electrolyte Market by Reagents & Analyzers (US$ Million), 2012-2018
Figure 2-12: Molecular Diagnostic Market (US$ Million), 2012-2018
Figure 2-13: Molecular Diagnostic Market by Reagents & Instruments (US$ Million), 2012-2018
Figure 2-14: Molecular Diagnostic Reagent Market by Segment, 2012-2018
Figure 2-15: Urinalysis Market (US$ Million), 2012-2018
Figure 2-16: Urinalysis Market by Reagents & Instruments (US$ Million), 2012-2018
Figure 2-17: Urinalysis Instruments Market by Segment, 2012-2018
Figure 2-18: Coagulation Market (US$ Million), 2012-2018
Figure 2-19: Coagulation Market by Reagents & Instruments (US$ Million), 2012-2018
Figure 2-20: Microbiology Market (US$ Million), 2012-2018
Figure 2-21: Microbiology Market by Reagents & Instruments (US$ Million), 2012-2018